Fig. 7From: Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectivesBiomarkers for neoadjuvant therapy in NSCLC. Schema illustrates the emerging biomarkers of tumor tissue, blood, host, and radiology for neoadjuvant therapy in NSCLCBack to article page